Re:Theranos – Statement of Deficiency from CMMS [pdf]
by cant_kant on Friday April 01, 2016 @06:16AM
(#11403841)
"In April and May 2015, a test to measure prostate-specific antigen, or PSA, failed quality-control checks 22% of the time. The PSA test is used to help detect prostate cancer."
Ouch....
I see a string of class action suits in the future.
Ouch.... I see a string of class action suits in the future.